SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Keravision(kera) -- Ignore unavailable to you. Want to Upgrade?


To: Sir Auric Goldfinger who wrote (237)10/7/1999 2:19:00 PM
From: oilbabe  Read Replies (1) | Respond to of 338
 
well, thanks for posting your short position so clearly. I heard them say 10 minutes quite clearly on CNBC.
2 things I took away from the segment. 500 trained doctors, and the concept of using this procedure for people who are hitting their 40's, and need the flexibility of change for reading ability. I would take 1/2 of most laser procedures. One eye lasix, one eye KERA. Could have been better, for sure, but the publicity was there, and the profit margin looks good.



To: Sir Auric Goldfinger who wrote (237)10/7/1999 3:12:00 PM
From: eyebalz  Read Replies (1) | Respond to of 338
 
Auric,

KERA also has a preferred convertible outstanding.

Lasix is a wonderful, fast and safe procedure.
Kera (intacts)is not.

Eyebalz